Payment overview · 2025
General Payments
$128.39
2 reported records · 2 companies
Healthcare provider profile · identity verified
Christianna Karr
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · WAKE FOREST, NC · NPI 1356867576
Verified facts
What the public records show
CMS Open Payments records show Christianna Karr received $128.39 in general payments during 2025 across 2 reported records.
Medtronic, Inc. accounted for 97.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$124.98 | 97.3% | 1 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $3.41 | 2.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $128.39 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AURORA EV-ICD MRI SURESCAN Normalized: aurora ev icd mri surescan |
Device | Medtronic, Inc. | $124.98 | 1 | 2025 |
Source payment records
|
|||||
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $3.41 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 426 | 126 |
| Amlodipine Besylate | Amlodipine Besylate | 388 | 119 |
| Lisinopril | Lisinopril | 267 | 81 |
| Gabapentin | Gabapentin | 216 | 77 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 209 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 182 | 60 |
| Losartan Potassium | Losartan Potassium | 178 | 62 |
| Omeprazole | Omeprazole | 168 | 61 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 151 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 151 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 144 | 45 |
| Fluticasone Propionate | Fluticasone Propionate | 135 | 54 |
| Trazodone Hcl | Trazodone Hcl | 123 | 33 |
| Meloxicam | Meloxicam | 119 | 42 |
| Metoprolol Succinate | Metoprolol Succinate | 117 | 40 |
| Famotidine | Famotidine | 110 | 39 |
| Metformin Hcl Er | Metformin Hcl | 108 | 36 |
| Potassium Chloride | Potassium Chloride | 98 | 33 |
| Metformin Hcl | Metformin Hcl | 90 | 34 |
| Furosemide | Furosemide | 88 | 33 |
| Jardiance | Empagliflozin | 84 | 19 |
| Sertraline Hcl | Sertraline Hcl | 81 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 73 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 71 | 26 |
| Eliquis | Apixaban | 70 | 18 |
| Ozempic | Semaglutide | 67 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 67 | 19 |
| Glipizide Er | Glipizide | 65 | 26 |
| Bupropion Xl | Bupropion Hcl | 58 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 56 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 52 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 51 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 51 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 23 |
| Carvedilol | Carvedilol | 46 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 46 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 45 | 13 |
| Montelukast Sodium | Montelukast Sodium | 45 | 13 |
| Mounjaro | Tirzepatide | 44 | 11 |
| Alprazolam | Alprazolam | 43 | 18 |
| Ezetimibe | Ezetimibe | 43 | 13 |
| Meclizine Hcl | Meclizine Hcl | 42 | 15 |
| Nystatin | Nystatin | 42 | 18 |
| Pregabalin | Pregabalin | 42 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 41 | 16 |
| Clonazepam | Clonazepam | 40 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 39 | 11 |
| Chlorthalidone | Chlorthalidone | 38 | 11 |
| Prednisone | Prednisone | 38 | 35 |
| Allopurinol | Allopurinol | 37 | 14 |
| Baclofen | Baclofen | 37 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 37 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 35 | suppressed |
| Topiramate | Topiramate | 35 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | 11 |
| Tamsulosin Hcl | Tamsulosin Hcl | 33 | 15 |
| Valsartan | Valsartan | 33 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | suppressed |
| Telmisartan | Telmisartan | 32 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 31 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 31 | 15 |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Spironolactone | Spironolactone | 30 | 13 |
| Trulicity | Dulaglutide | 30 | suppressed |
| Ibuprofen | Ibuprofen | 29 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 28 | suppressed |
| Klor-Con M20 | Potassium Chloride | 28 | 15 |
| Simvastatin | Simvastatin | 28 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 26 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Methocarbamol | Methocarbamol | 26 | 14 |
| Mirtazapine | Mirtazapine | 26 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 25 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 24 | 12 |
| Buspirone Hcl | Buspirone Hcl | 24 | suppressed |
| Linzess | Linaclotide | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 23 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Celecoxib | Celecoxib | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 21 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 18 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Cephalexin | Cephalexin | 16 | 14 |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Euthyrox | Levothyroxine Sodium | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 15 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Atenolol | Atenolol | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 14 |
| Humalog Kwikpen U-200 | Insulin Lispro | 14 | suppressed |
| Lorazepam | Lorazepam | 14 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Finasteride | Finasteride | 12 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $128.39 · 2 records | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN, LifeVest | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error